The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia
Open accessAbstract
In acute myeloid leukaemia (AML), the cell of origin, nature and biological consequences of initiating lesions, and order of subsequent mutations remain poorly understood, as AML is typically diagnosed without observation of a pre-leukaemic phase. Here, highly purified haematopoietic stem cells (HSCs), progenitor and mature cell fractions from the blood of AML patients were found to contain recurrent DNMT3A mutations (DNMT3A(mut)) at high allele frequency, but without coincident NPM1 mutations (NPM1c) present in AML blasts. DNMT3A(mut)-bearing HSCs showed a multilineage repopulation advantage over non-mutated HSCs in xenografts, establishing their identity as pre-leukaemic HSCs. Pre-leukaemic HSCs were found in remission samples, indicating that they survive chemotherapy. Therefore DNMT3A(mut) arises early in AML evolution, probably in HSCs, leading to a clonally expanded pool of pre-leukaemic HSCs from which AML evolves. Our findings provide a paradigm for the detection and treatment of pre-leukaemic clones before the acquisition of additional genetic lesions engenders greater therapeutic resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent studies in patients with AML have confirmed the functional importance and clinical significance of preleukemic stem cell populations as the cellular origin of leukemia-initiating cells in human disease27, 48.”
From Minimal PU.1 reduction induces a preleukemic state and promotes development of acute myeloid leukemia (2015) · cites this paper as [48]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“DNMT3A is also recurrently mutated in blood diseases such as acute myeloid leukemia (AML; ref. 9) and myelodysplastic syndromes (MDS; ref. 10) where it functions as an initiating mutation (11).”
From Txnip Enhances Fitness of Dnmt3a -Mutant Hematopoietic Stem Cells via p21 (2022) · cites this paper as [11]
Experimental — accuracy not yet measuredIn the citing paper
“In later studies, DNA sequencing of HSCs from AML patients in remission revealed that stem cells with only a single driver mutation were often present, suggesting that pre-malignant clonal hematopoiesis was a generalizable finding in AML 23–25.”
From Clonal hematopoiesis in human aging and disease (2019) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genetic Alterations during Colorectal-Tumor Development
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., de Vries-Smits, A. M. M., & Bos, J. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190901 · Cited by 6,704
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
The Cancer Genome Atlas Research Network (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301689 · Cited by 5,078
Mutational landscape and significance across 12 major cancer types
Kandoth, C., McLellan, M. D., Vandin, F., Ye, K., Niu, B., Lu, C., Xie, M., Zhang, Q., McMichael, J. F., Wyczalkowski, M. A., et al. (2013) · Nature · doi:10.1038/nature12634 · Cited by 4,419
Greaves, M., & Maley, C. C. (2012) · Nature · doi:10.1038/nature10762 · Cited by 3,162
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., et al. (2010) · Nature · doi:10.1038/nature09515 · Cited by 2,502
Hu, Y., & Smyth, G. K. (2009) · Journal of Immunological Methods · doi:10.1016/j.jim.2009.06.008 · Cited by 2,084
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
Ding, L., Ley, T. J., Larson, D. E., Miller, C. A., Koboldt, D. C., Welch, J. S., Ritchey, J. K., Young, M. A., Lamprecht, T., McLellan, M. D., et al. (2012) · Nature · doi:10.1038/nature10738 · Cited by 1,993
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
Patel, J. P., Gönen, M., Figueroa, M. E., Fernandez, H. F., Sun, Z., Racevskis, J., Vlierberghe, P. V., Dolgalev, I., Thomas, S., Aminova, O., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112304 · Cited by 1,990
DNMT3A Mutations in Acute Myeloid Leukemia
Ley, T. J., Ding, L., Walter, M. J., McLellan, M. D., Lamprecht, T., Larson, D. E., Kandoth, C., Payton, J. E., Baty, J., Welch, J., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1005143 · Cited by 1,983
The patterns and dynamics of genomic instability in metastatic pancreatic cancer
Campbell, P. J., Yachida, S., Mudie, L. J., Stephens, P. J., Pleasance, E. D., Stebbings, L. A., Morsberger, L. A., Latimer, C., McLaren, S., Lin, M.-L., et al. (2010) · Nature · doi:10.1038/nature09460 · Cited by 1,317
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 1,000
The Role of IDH Mutations in Acute Myeloid Leukemia
Bravo, G. M., & Dinardo, C. D. (2018) · Future Oncology · doi:10.2217/fon-2017-0523 · Cited by 128
Characterization of Large Structural Genetic Mosaicism in Human Autosomes
Machiela, M. J., Zhou, W., Sampson, J. N., Dean, M. C., Jacobs, K. B., Black, A., Brinton, L. A., Chang, I., Chen, C., Chen, C., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.01.011 · Cited by 122
Self-citationPersistence of DNMT 3A mutations at long‐term remission in adult patients with AML
Pløen, G. G., Nederby, L., Guldberg, P., Hansen, M., Ebbesen, L. H., Jensen, U. B., Hokland, P., & Aggerholm, A. (2014) · British Journal of Haematology · doi:10.1111/bjh.13062 · Cited by 126
Hajj, H. E., Dassouki, Z., Berthier, C., Raffoux, E., Adès, L., Legrand, O., Hleihel, R., Şahin, U., Tawil, N., Salameh, A., et al. (2015) · Blood · doi:10.1182/blood-2014-11-612416 · Cited by 120
RNA Splicing Modulation Selectively Impairs Leukemia Stem Cell Maintenance in Secondary Human AML
Crews, L. A., Balaian, L., Santos, N. P. D., Leu, H. S., Court, A. C., Lazzari, E., Sadarangani, A., Zipeto, M., Clair, J. J. L., Villa, R., et al. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.08.003 · Cited by 123
Clonal hematopoiesis and inflammation: Partners in leukemogenesis and comorbidity
Cook, E. K., Luo, M., & Rauh, M. J. (2020) · Experimental Hematology · doi:10.1016/j.exphem.2020.01.011 · Cited by 124
Pathophysiology of Acute Myeloid Leukemia
Wachter, F., & Pikman, Y. (2024) · Acta Haematologica · doi:10.1159/000536152 · Cited by 140
Stem and progenitor cell alterations in myelodysplastic syndromes
Shastri, A., Will, B., Steidl, U. G., & Verma, A. K. (2017) · Blood · doi:10.1182/blood-2016-10-696062 · Cited by 123
Shah, N. J., Najibi, A. J., Shih, T., Mao, A. S., Sharda, A., Scadden, D. T., & Mooney, D. J. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0503-3 · Cited by 123
Directly targeting transcriptional dysregulation in cancer
Gonda, T. J., & Ramsay, R. G. (2015) · Nature reviews. Cancer · doi:10.1038/nrc4018 · Cited by 121
Hematopoietic differentiation is required for initiation of acute myeloid leukemia
Ye, M., Zhang, H., Yang, H., Koche, R., Staber, P., Cusan, M., Levantini, E., Welner, R., Bach, C., Zhang, J.-Y., et al. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.08.011 · Cited by 112
The role of TP53 in acute myeloid leukemia: Challenges and opportunities
Barbosa, K., Li, S., Adams, P. D., & Deshpande, A. J. (2019) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22796 · Cited by 118
Clonal hematopoiesis and measurable residual disease assessment in acute myeloid leukemia
Hasserjian, R. P., Steensma, D. P., Graubert, T. A., & Ebert, B. L. (2020) · Blood · doi:10.1182/blood.2019004770 · Cited by 118
Jan, M., Ebert, B. L., & Jaiswal, S. (2016) · Seminars in Hematology · doi:10.1053/j.seminhematol.2016.10.002 · Cited by 119
Kim, T., Tyndel, M. S., Kim, H. J., Ahn, J.-S., Choi, S. H., Park, H. J., Kim, Y.-K., Kim, S. Y., Lipton, J. H., Zhang, Z., et al. (2017) · Blood · doi:10.1182/blood-2016-04-708560 · Cited by 133
Self-citation5-hydroxymethylcytosine in cancer: significance in diagnosis and therapy
Vasanthakumar, A., & Godley, L. A. (2015) · Cancer Genetics · doi:10.1016/j.cancergen.2015.02.009 · Cited by 116
Gu, X., Ebrahem, Q., Mahfouz, R. Z., Hasipek, M., Enane, F. O., Radivoyevitch, T., Rapin, N., Przychodzen, B. P., Hu, Z., Balusu, R., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97117 · Cited by 118
Clonal fate mapping quantifies the number of haematopoietic stem cells that arise during development
Henninger, J. E., Santoso, B., Hans, S., Durand, E. M., Moore, J. L., Mosimann, C., Brand, M., Traver, D. J., & Zon, L. I. (2016) · Nature Cell Biology · doi:10.1038/ncb3444 · Cited by 116
Han, L., Zhang, Q., Dail, M., Shi, C., Cavazos, A., Ruvolo, V. R., Zhao, Y., Kim, E. S., Rahmani, M., Mak, D. H. F., et al. (2019) · Haematologica · doi:10.3324/haematol.2018.205534 · Cited by 109
Self-citationCancer stem cells and immunoresistance: clinical implications and solutions.
Codony‐Servat, J., & Rosell, R. (2015) · PubMed Central · doi:10.3978/j.issn.2218-6751.2015.12.11 · Cited by 112
Preclinical efficacy of MEK inhibition in Nras-mutant AML
Burgess, M. R., Hwang, E., Firestone, A. J., Huang, T. Q., Xu, J., Zuber, J. A., Bohin, N., Wen, T., Kogan, S. C., Haigis, K. M., et al. (2014) · Blood · doi:10.1182/blood-2014-05-574582 · Cited by 111
Shih, A. H., Meydan, C., SHANK, K. R., Garrett-Bakelman, F. E., Ward, P. S., Intlekofer, A. M., Nazir, A., Stein, E. M., Knapp, K. M., Glass, J. L., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-1049 · Cited by 113
Epigenetic Priming in Cancer Initiation
Vicente‐Dueñas, C., Hauer, J., Cobaleda, C., Borkhardt, A., & Sánchez-Garcı́a, I. (2018) · Trends in cancer · doi:10.1016/j.trecan.2018.04.007 · Cited by 107
Novel biological insights in T-cell acute lymphoblastic leukemia
Durinck, K., Goossens, S., Peirs, S., Wallaert, A., Loocke, W. V., Matthijssens, F., Pieters, T., Milani, G., Lammens, T., Rondou, P., et al. (2015) · Experimental Hematology · doi:10.1016/j.exphem.2015.05.017 · Cited by 111
Wong, T. N., Miller, C. A., Klco, J. M., Petti, A. A., Demeter, R., Helton, N., Li, T., Fulton, R. S., Heath, S. E., Mardis, E. R., et al. (2015) · Blood · doi:10.1182/blood-2015-10-677021 · Cited by 108
Tissue-specific DNA demethylation is required for proper B-cell differentiation and function
Orlanski, S., Labi, V., Reizel, Y., Spiro, A., Lichtenstein, M., Levin-Klein, R., Koralov, S. B., Skversky‐Blocq, Y., Rajewsky, K., Cedar, H., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1604365113 · Cited by 103
Mutations of myelodysplastic syndromes (MDS): An update
Ganguly, B. B., & Kadam, N. N. (2016) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2016.04.009 · Cited by 108
Clonal Hematopoiesis of Indeterminate Potential
Heuser, M., Thol, F. R., & Ganser, A. (2016) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2016.0317 · Cited by 110
Prospective Isolation and Characterization of Genetically and Functionally Distinct AML Subclones
de Boer, B., Prick, J. C. M., Pruis, M. G. M., Keane, P., Imperato, M. R., Jaques, J., Brouwers-Vos, A. Z., Hogeling, S. M., Woolthuis, C. M., Nijk, M. T., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.08.014 · Cited by 101
Combined Loss of Tet1 and Tet2 Promotes B Cell, but Not Myeloid Malignancies, in Mice
Zhao, Z., Chen, L., Dawlaty, M. M., Pan, F., Weeks, O. I., Zhou, Y., Cao, Z., Shi, H., Wang, J., Lin, L., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.10.037 · Cited by 104
Self-citationAberrant DNA Methylation in Acute Myeloid Leukemia and Its Clinical Implications
Yang, X., Wong, M. P. M., & Ng, R. K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184576 · Cited by 105
CHIP Happens: Clonal Hematopoiesis of Indeterminate Potential and Its Relationship to Solid Tumors
Reed, S. C., Croessmann, S., & Park, B. H. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-2598 · Cited by 112
CHIP, CCUS, and Other Acronyms: Definition, Implications, and Impact on Practice
Dezern, A. E., Malcovati, L., & Ebert, B. L. (2019) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_239083 · Cited by 102
Stiehl, T., Baran, N., Ho, A. D., & Marciniak-Czochra, A. K. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2508 · Cited by 97
Debarri, H., Lebon, D., Roumier, C., Cheok, M. H.-C., Marceau‐Renaut, A., Nibourel, O., Geffroy, S., Hélevaut, N., Rousselot, P. H., Gruson, B., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5645 · Cited by 108
Koya, J., Kataoka, K., Sato, T., Bando, M., Kato, Y., Tsuruta-Kishino, T., Kobayashi, H., Narukawa, K., Miyoshi, H., Shirahige, K., et al. (2016) · Nature Communications · doi:10.1038/ncomms10924 · Cited by 99
IL1RAP potentiates multiple oncogenic signaling pathways in AML
Mitchell, K., Barreyro, L., Todorova, T. I., Taylor, S. J., Antony-Debré, I., Narayanagari, S.-R., Carvajal, L. A., Leite, J., Piperdi, Z., Pendurti, G., et al. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20180147 · Cited by 97
Discovering the drivers of clonal hematopoiesis
Pich, O., Reyes-Salazar, I., González-Pérez, A., & López-Bigas, N. (2022) · Nature Communications · doi:10.1038/s41467-022-31878-0 · Cited by 100
Divergent Effects of Dnmt3a and Tet2 Mutations on Hematopoietic Progenitor Cell Fitness
Ostrander, E. L., Kramer, A. C., Mallaney, C., Celik, H., Koh, W. K., Fairchild, J., Haussler, E., Zhang, C. R., & Challen, G. A. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.02.011 · Cited by 97
Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia
Naldini, M. M., Casirati, G., Barcella, M., Rancoita, P. M. V., Cosentino, A., Caserta, C., Pavesi, F., Zonari, E., Desantis, G., Gilioli, D., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36969-0 · Cited by 97
Beneyto-Calabuig, S., Merbach, A. K., Kniffka, J.-A., Antes, M., Szu-Tu, C., Rohde, C., Waclawiczek, A., Stelmach, P., Gräßle, S., Pervan, P., et al. (2023) · Cell Stem Cell · doi:10.1016/j.stem.2023.04.001 · Cited by 96
Acute myeloid leukaemia genomics
Medinger, M., & Passweg, J. R. (2017) · British Journal of Haematology · doi:10.1111/bjh.14823 · Cited by 98
Effective Drug Concentration and Selectivity Depends on Fraction of Primitive Cells
Lica, J. J., Wieczór, M., Grabe, G. J., Heldt, M., Jancz, M., Misiak, M., Gucwa, K., Brankiewicz, W., Maciejewska, N., Stupak, A., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094931 · Cited by 95
How I treat refractory and relapsed acute myeloid leukemia
Thol, F. R., Döhner, H., & Ganser, A. (2023) · Blood · doi:10.1182/blood.2023022481 · Cited by 98
Emerging concepts of epigenetic dysregulation in hematological malignancies
Ntziachristos, P., Abdel-Wahab, O. I., & Aifantis, I. (2016) · Nature Immunology · doi:10.1038/ni.3517 · Cited by 99
Antisense STAT3 inhibitor decreases viability of myelodysplastic and leukemic stem cells
Shastri, A., Choudhary, G. S., Teixeira, M., Gordon-Mitchell, S., Ramachandra, N., Bernard, L., Bhattacharyya, S., Lopez, R., Pradhan, K., Giricz, O., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120156 · Cited by 95
Yu, J., Li, Y., Li, T., Li, Y., Xing, H., Sun, H., Sun, L., Wan, D., Liu, Y., Xie, X., et al. (2020) · Experimental Hematology and Oncology · doi:10.1186/s40164-019-0158-5 · Cited by 95
Malcovati, L., & Cazzola, M. (2015) · Hematology · doi:10.1182/asheducation-2015.1.299 · Cited by 96
Extramedullary Hematopoiesis of the Liver and Spleen
Cenariu, D., Iluta, S., Zimța, A., Petrushev, B., Qian, L., Dîrzu, N., Tomuleasa, C., Bumbea, H., & Zaharie, F. V. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10245831 · Cited by 105
The Impact of DNA Methylation in Hematopoietic Malignancies
Guillamot, M., Cimmino, L., & Aifantis, I. (2016) · Trends in cancer · doi:10.1016/j.trecan.2015.12.006 · Cited by 96
Identification of cell-type-specific mutations in nodal T-cell lymphomas
Nguyen, T. B., Sakata‐Yanagimoto, M., Asabe, Y., Matsubara, D., Kano, J., Yoshida, K., Shiraishi, Y., Chiba, K., Tanaka, H., Miyano, S., et al. (2017) · Blood Cancer Journal · doi:10.1038/bcj.2016.122 · Cited by 92
Driver mutations in acute myeloid leukemia
Kishtagari, A., Levine, R. L., & Viny, A. D. (2020) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000567 · Cited by 100
Understanding of leukemic stem cells and their clinical implications
Wang, X., Huang, S., & Chen, J. (2017) · Molecular Cancer · doi:10.1186/s12943-016-0574-7 · Cited by 92
High NPM1-mutant allele burden at diagnosis predicts unfavorable outcomes in de novo AML
Patel, S. S., Kuo, F. C., Gibson, C. J., Steensma, D. P., Soiffer, R. J., Alyea, E. P., Chen, Y.-B. A., Fathi, A. T., Graubert, T. A., Brunner, A. M., et al. (2018) · Blood · doi:10.1182/blood-2018-01-828467 · Cited by 88
The cell of origin and the leukemia stem cell in acute myeloid leukemia
Chopra, M., & Bohlander, S. K. (2019) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22805 · Cited by 95
Signaling pathways in the regulation of cancer stem cells and associated targeted therapy
Wang, M., & Wu, M. (2022) · MedComm · doi:10.1002/mco2.176 · Cited by 96
Leukaemia 'firsts' in cancer research and treatment
Greaves, M. F. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.3 · Cited by 90
Greif, P. A., Hartmann, L., Vosberg, S., Stief, S. M., Mattes, R., Hellmann, I., Metzeler, K. H., Herold, T., Bamopoulos, S. A., Kerbs, P., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2344 · Cited by 88
Mutational Landscape of Pediatric Acute Lymphoblastic Leukemia
Ding, L., Sun, Q., Tan, K. T., Chien, W., Mayakonda, A., Yeoh, A. E. J., Kawamata, N., Nagata, Y., Xiao, J., Loh, X.-Y., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-1303 · Cited by 87
The evolving genomic landscape of myeloproliferative neoplasms
Nangalia, J., & Green, T. R. (2014) · Hematology · doi:10.1182/asheducation-2014.1.287 · Cited by 87
Boutzen, H., Saland, E., Larrue, C., de Toni, F., Gales, L., Castelli, F. A., Cathebas, M., Zaghdoudi, S., Stuani, L., Kaoma, T., et al. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20150736 · Cited by 92
Ordering of mutations in acute myeloid leukemia with partial tandem duplication of MLL (MLL-PTD)
Sun, Q.-Y., Ding, L.-W., Tan, K. T., Chien, W., Mayakonda, A., Lin, D.-C., Loh, X.-Y., Xiao, J.-F., Meggendorfer, M., Alpermann, T., et al. (2016) · Leukemia · doi:10.1038/leu.2016.160 · Cited by 87
Cole, C. B., Russler-Germain, D. A., Ketkar, S., Verdoni, A. M., Smith, A. M., Bangert, C. V., Helton, N. M., Guo, M., Klco, J. M., O’Laughlin, S., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci93041 · Cited by 84
CHIP, ICUS, CCUS and other four-letter words
Bejar, R. L. (2017) · Leukemia · doi:10.1038/leu.2017.181 · Cited by 90
Underlying Causes and Therapeutic Targeting of the Inflammatory Tumor Microenvironment
Comen, E. A., Bowman, R. L., & Kleppe, M. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00056 · Cited by 87
Clonal Hematopoiesis of Indeterminate Potential Reshapes Age-Related CVD
Khetarpal, S. A., Qamar, A., Bick, A. G., Fuster, J. J., Kathiresan, S., Jaiswal, S., & Natarajan, P. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.05.045 · Cited by 88
Epigenetic Regulators as the Gatekeepers of Hematopoiesis
Rodrigues, C. P., Shvedunova, M., & Akhtar, A. (2020) · Trends in Genetics · doi:10.1016/j.tig.2020.09.015 · Cited by 99
Single cell analysis of clonal architecture in acute myeloid leukaemia
Potter, N. E., Miraki‐Moud, F., Ermini, L., Titley, I., Vijayaraghavan, G., Papaemmanuil, E., Campbell, P. J., Gribben, J. G., Taussig, D. C., & Greaves, M. F. (2018) · Leukemia · doi:10.1038/s41375-018-0319-2 · Cited by 92
Epigenetics in the hematologic malignancies
Fong, C. Y., Morison, J., & Dawson, M. A. (2014) · Haematologica · doi:10.3324/haematol.2013.092007 · Cited by 87
The serum tryptase test: an emerging robust biomarker in clinical hematology
Valent, P., Sperr, W. R., Sotlar, K., Reiter, A., Akin, C., Gotlib, J., Horny, H.-P., & Arock, M. (2014) · Expert Review of Hematology · doi:10.1586/17474086.2014.955008 · Cited by 83
NPM1 mutated AML can relapse with wild-type NPM1: persistent clonal hematopoiesis can drive relapse
Höllein, A., Meggendorfer, M., Dicker, F., Jeromin, S., Nadarajah, N., Kern, W., Haferlach, C., & Haferlach, T. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018023432 · Cited by 84
Leukemic Stem Cells: From Leukemic Niche Biology to Treatment Opportunities
Marchand, T., & Pinho, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.775128 · Cited by 94
miR-29a maintains mouse hematopoietic stem cell self-renewal by regulating Dnmt3a
Hu, W., Dooley, J., Chung, S. S., Chandramohan, D., Cimmino, L., Mukherjee, S., Mason, C. E., Strooper, B. D., Liston, A., & Park, C. Y. (2015) · Blood · doi:10.1182/blood-2014-06-585273 · Cited by 86
Pardanani, A. D., Lasho, T. L., Elala, Y. C., Wassie, E. A., Finke, C. M., Reichard, K. K., Chen, D., Hanson, C. A., Ketterling, R. P., & Tefferi, A. (2016) · American Journal of Hematology · doi:10.1002/ajh.24426 · Cited by 82
Conditional knockin of Dnmt3a R878H initiates acute myeloid leukemia with mTOR pathway involvement
Dai, Y., Wang, Y., Huang, J.-Y., Li, X., Shi, X., Xu, J., Lu, J., Su, X., Yang, Y., Zhang, W., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1703476114 · Cited by 82
The European Hematology Association Roadmap for European Hematology Research: a consensus document
Engert, A., Balduini, C., Brand, A., Coiffier, B., Cordonnier, C., Dohner, H., de Wit, T. D., Eichinger, S., Fibbe, W., Green, T., et al. (2016) · Haematologica · doi:10.3324/haematol.2015.136739 · Cited by 81
Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia
Hou, H., Liu, C., Kuo, Y., Chou, W., Tsai, C., Lin, C., Lin, L., Tseng, M., Chiang, Y., Liu, M.-C., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7000 · Cited by 84
Venetoclax therapy and emerging resistance mechanisms in acute myeloid leukaemia
Nwosu, G. O., Ross, D. M., Powell, J. A., & Pitson, S. M. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06810-7 · Cited by 80
RUNX1 Mutations in Inherited and Sporadic Leukemia
Bellissimo, D. C., & Speck, N. A. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00111 · Cited by 81
Mutational analysis of disease relapse in patients allografted for acute myeloid leukemia
Quek, L. S., Ferguson, P., Metzner, M., Ahmed, I., Kennedy, A., Garnett, C., Jeffries, S., Walter, C. U., Piechocki, K., Timbs, A., et al. (2016) · Blood Advances · doi:10.1182/bloodadvances.2016000760 · Cited by 81
Clinical implications of recurrent gene mutations in acute myeloid leukemia
Yu, J., Li, Y., Zhang, D., Wan, D., & Jiang, Z. (2020) · Experimental Hematology and Oncology · doi:10.1186/s40164-020-00161-7 · Cited by 90
Concise Review: Age-Related Clonal Hematopoiesis: Stem Cells Tempting the Devil
Busque, L., Buscarlet, M., Mollica, L. R., & Levine, R. L. (2018) · Stem Cells · doi:10.1002/stem.2845 · Cited by 79
Modeling the process of human tumorigenesis
Balani, S., Nguyen, L. V., & Eaves, C. J. (2017) · Nature Communications · doi:10.1038/ncomms15422 · Cited by 80
SF3B1-initiating mutations in MDS-RSs target lymphomyeloid hematopoietic stem cells
Blanco, T. M., Dimitriou, M., Woll, P. S., Karimi, M., Elvarsdóttir, E. M., Conte, S., Tobiasson, M., Jansson, M., Douagi, I., Moarii, M., et al. (2017) · Blood · doi:10.1182/blood-2017-03-776070 · Cited by 80
Jabbour, E. J., Short, N. J., Jorgensen, J. L., Yilmaz, M. E., Ravandi, F., Wang, S. A., Thomas, D. A., Khoury, J. D., Champlin, R. E., Khouri, I. F., et al. (2016) · Cancer · doi:10.1002/cncr.30264 · Cited by 78
Hou, H., & Tien, H. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-00674-7 · Cited by 86
How I diagnose and treat NPM1 -mutated AML
Falini, B., Brunetti, L., & Martelli, M. P. (2020) · Blood · doi:10.1182/blood.2020008211 · Cited by 78
Actinomycin D Targets NPM1c-Primed Mitochondria to Restore PML-Driven Senescence in AML Therapy
Wu, H.-C., Rérolle, D., Berthier, C., Hleihel, R., Sakamoto, T., Quentin, S., Benhenda, S., Morganti, C., Wu, C., Conte, L., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0177 · Cited by 75
Mutations in the BCR-ABL1 Kinase Domain and Elsewhere in Chronic Myeloid Leukemia
Soverini, S., Benedittis, C. D., Mancini, M., & Martinelli, G. (2015) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2015.02.035 · Cited by 77
Ferrone, C. K., Blydt-Hansen, M., & Rauh, M. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020626 · Cited by 80
Scheller, M., Ludwig, A. K., Göllner, S., Rohde, C., Krämer, S., Stäble, S., Janssen, M., Müller, J.-A., He, L., Bäumer, N., et al. (2021) · Nature Cancer · doi:10.1038/s43018-021-00213-9 · Cited by 73
Acute Myeloid Leukemia Stem Cells: Origin, Characteristics, and Clinical Implications
Long, N. A., Golla, U., Sharma, A., & Claxton, D. F. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10308-6 · Cited by 77
Classification and risk assessment in AML: integrating cytogenetics and molecular profiling
Moarii, M., & Papaemmanuil, E. (2017) · Hematology · doi:10.1182/asheducation-2017.1.37 · Cited by 76
Clonal dynamics of haematopoiesis across the human lifespanPreprint
Mitchell, E., Chapman, M. S., Williams, N., Dawson, K. J., Mende, N., Calderbank, E. F., Jung, H., Mitchell, T. J., Coorens, T. H. H., Spencer, D. H., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.16.456475 · Cited by 74
Connections Between Clonal Hematopoiesis, Cardiovascular Disease, and Cancer
Arguelles, O. C., Jaiswal, S., Shlush, L. I., Moslehi, J. J., Schimmer, A. D., Barac, A., & Thavendiranathan, P. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.0302 · Cited by 73
Self-citationCharacteristics of DNMT3A mutations in acute myeloid leukemia
Park, D. J., Kwon, A., Cho, B., Kim, H., Hwang, K.-A., Kim, M., & Kim, Y. (2020) · Blood Research · doi:10.5045/br.2020.55.1.17 · Cited by 80
Self-citationA Rapid Molecular Approach for Chromosomal Phasing
Regan, J. F., Kamitaki, N., Legler, T. C., Cooper, S., Klitgord, N., Karlin-Neumann, G. A., Wong, T. W. C., Hodges, S. P., Koehler, R. T., Tzonev, S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118270 · Cited by 74
A generalized theory of age-dependent carcinogenesis
Rozhok, A. I., & DeGregori, J. V. (2019) · eLife · doi:10.7554/elife.39950 · Cited by 74
Mitochondrial dependency in progression of acute myeloid leukemia
Basak, N. P., & Banerjee, S. (2015) · Mitochondrion · doi:10.1016/j.mito.2015.01.006 · Cited by 75
Advances in Acute Myeloid Leukemia: Recently Approved Therapies and Drugs in Development
Stanchina, M., Soong, D., Zheng-Lin, B., Watts, J. M., & Taylor, J. (2020) · Cancers · doi:10.3390/cancers12113225 · Cited by 72
Metadata
- Authors
- Shlush, L. I., Zandi, S., Mitchell, A., Chen, W. C., Brandwein, J. M., Gupta, V., Kennedy, J. A., Schimmer, A. D., Schuh, A. C., Yee, K. W., McLeod, J. L., Doedens, M., Medeiros, J. J. F., Marke, R., Kim, H. J., Lee, K., McPherson, J. D., Hudson, T. J., Pan-Leukemia Gene Panel Consortium, T. H., Brown, A. M. K., Yousif, F., Trinh, Q. M., Stein, L. D., Minden, M. D., Wang, J. C. Y., & Dick, J. E.
- Affiliations
- University Health Network (CA)
- Chonnam National University (KR)
- Ontario Institute for Cancer Research (CA)
- Corresponding author
- Dick, John E.
- ORCID
- Venue
- Nature
- Published
- 2014-02-12
- Volume
- 506
- Issue
- 7488
- Pages
- 328-333
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4991939
- OpenAlex
- W2076031927
- Cited by
- 1,443
- References
- 53
- Citations by year
- 2026: 50 · 2025: 48 · 2024: 75 · 2023: 95 · 2022: 94 · 2021: 110 · 2020: 136 · 2019: 131 · 2018: 139 · 2017: 160 · 2016: 153 · 2015: 159 · 2014: 88
- FWCI
- 132.63
- Type
- journal article
- Language
- en
- Update notices
- correction (2014-04-16)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- Hospital for Sick Children
- Canadian Institutes of Health Research (105367_1)
- National Cancer Institute (R21CA152613)
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Keywords
- acute myeloid leukemia, DNMT3A mutation, NPM1 mutation, clonal evolution, treatment resistance, relapse, clonal expansion, chemotherapy remission, tumor heterogeneity, xenografts, mutation order, hematopoiesis
- MeSH terms
- DNA Methyltransferase 3A, Nucleophosmin, Animals, Cell Differentiation, Cell Division, Clone Cells, DNA (Cytosine-5-)-Methyltransferases, Female, Hematopoiesis, Hematopoietic Stem Cells, Humans, Isocitrate Dehydrogenase, Mutation, Neoplasm Transplantation, Nuclear Proteins, Remission Induction, T-Lymphocytes, Neoplastic Stem Cells, Leukemia, Myeloid, Acute, Mice, SCID, Mice, Inbred NOD, Drug Resistance, Neoplasm, Cell Lineage, Mice, Heterografts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
